MILGAMMA IN NEUROLOGICAL PRACTICE
- Authors: Akarachkova Y1, Akarachkova E.S.1
-
Affiliations:
- Issue: No 10 (2010)
- Pages: 17-20
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278450
- ID: 278450
Cite item
Full Text
Abstract
The article summarizes data for the use of Milgamma in neurological practice, particularly for neuropathic pain and acute low-back pain. The drug includes vitamin B complex, which in therapeutic doses has a marked neuroprotective effect and, at the same time potentiates analgesia. Recommendations on dosage and duration of therapy with Milgamma are presented.
References
- Kempler P, Tesfaye S, Chaturvedi N, et al. Eurodiab IDDM Complications Study Group Autonomic neuropathy is associated with increased cardiovascular risk factors the EURODIAB IDDM Complications Study. Diabet Med 2002;19(11):900-09.
- Kempler P (ed.). Neuropathies. Nerve Dysfunction of Diabetic and Other Origin. Budarest/Hungary, Springer Verlag. 1997.
- Kempler P. Autonomic neuropathy: a marker of cardiovascular risc. Br J Diabetes Vasc Dis 2003;3:84-90.
- Greb A, Bitsch R. Comparative bioavailability of various thiamine derivatives after oral administration. Int J Clin Pharm Ther 1998;36:216-21.
- Brownlee M. Boichemistry and molecular cell biology of diabetic complication. Nature 2001;414(6865):813-20.
- Громова О.А. Магний и пиридоксин: основы знаний. М., 2006. 223 с.
- Lourenco R, Camilo ME. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 2002;17(6):262-70.
- Шварков С.Б., Акарачкова Е.С. Коррекции энергетического и электролитного баланса препаратами магния и пиридоксина при неврологических заболеваниях. М., 2007. 31с.
- Данилов А.Б. Применение витаминов группы В при болях в спине: новые анальгетики? // РМЖ. 2008. Спец. Выпуск. "Болевой синдром". С. 37-39.
- Мкртумян А.М., Подачина С.В. Мильгамма композитум - препарат выбора в лечении диабетической нейропатии // РМЖ. 2008. Т. 16. № 28. С. 1887-91.
- Ledermann H, Wiedey KD. Behandlung der manifesten diabetischen Polyneuropathie. Therapie-wochei 1989;(39):1445-49.
- Stracke LL, Lindemann A, Federlin K. A benfoti-amine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diab 1996;104:311-16.
- Haupt E, Ledermann H, Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 2005;43(2):71-77.
- Preedy VR, Ohlendieck K, Adachi J, et al. The important of alcohol-induced muscle disease. J Muscle Res Cell Motil 2003;24(1):55-63.
- Woelk H, Lehrl S, et al. Benfotiamine in the treatment of alcoholic polyneuropathy (BAP-I-Study). Alcohol Alcohol 1998;33(6):631-38.
Supplementary files
